In a recent Bloomberg Law article DrugPatentWatch data is used to show a decrease in patent litigation. This likely means fewer generic entrants and less opportunities for consumers to enjoy lower drug prices
.
How long might this last? Read more at https://news.bloomberglaw.com/pharma-and-life-sciences/virus-delays-few-approvals-dry-up-generic-drug-lawsuits-in-2020
